• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

0
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
A white sign featuring the Pfizer logo
HealthGSK, Pfizer RSV shots must warn about rare paralysis risk
By BloombergJanuary 8, 2025
HealthPfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
By Jennifer FieldsJanuary 3, 2025
CommentaryAs activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
HealthPneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By Lindsey LeakeOctober 22, 2024
CommentaryHere are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
By Jeffrey Sonnenfeld and Steven TianOctober 10, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
FinancePfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
HealthRSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
By Lindsey LeakeOctober 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
HealthCOVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
As of March 2024, the Centers for Disease Control and Prevention no longer advises a five-day isolation period when you test positive for COVID-19, but recommends taking other precautions once your symptoms subside.
HealthGot COVID? Here are the new 2024 isolation guidelines
By Lindsey LeakeSeptember 27, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
HealthCould it be COVID? Here are the symptoms to watch out for in 2024
By Lindsey LeakeSeptember 21, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
A bathroom scale is surrounded by colorful pills.
HealthPharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
By Damian Garde and BloombergJuly 11, 2024
MagazineMeet the ‘70-Year Club’: 49 companies have stayed at the top of the Fortune 500 for decades. Here are 4 keys to their longevity
By Nicolas Rapp and Matthew HeimerJune 4, 2024
people walking outside La Defense area in Paris
FinanceFrance bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive
By Prarthana PrakashMay 13, 2024
0
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.